GLP-1 Medications May Lower Alzheimer’s Disease Risk, New Research Suggests

Emerging research links GLP-1 diabetes medications to lower Alzheimer's risk, but experts caution that evidence remains preliminary.

Emerging research links GLP-1 diabetes medications to lower Alzheimer's risk, but experts caution that evidence remains preliminary.
Research suggests air pollution may accelerate amyloid accumulation in blood—a potential early warning sign of Alzheimer's disease.

Air pollution ages young adult brains to match patterns of Alzheimer's disease before age 35.
New blood tests for Alzheimer's markers reveal how air pollution may accelerate amyloid accumulation in the brain decades before symptoms appear.

Researchers now trace Alzheimer's origins to decades of environmental exposure—not just genes or age.

Living in areas with sustained high air pollution accelerates cognitive decline in people with Alzheimer's disease—one year of poor air quality can measurably worsen existing neurodegeneration.

Your zip code predicts Alzheimer's risk more accurately than your genes—and most people don't realize it.

Wildfire smoke raises dementia risk 10 times higher than regular air pollution, with new research quantifying the specific brain damage it triggers.

Breathing polluted air for years may accelerate cognitive decline through brain inflammation and nerve damage, starting earlier than researchers once thought.

The olfactory bulb serves as a direct highway for air pollutants into the Alzheimer's-vulnerable brain, potentially revealing damage decades before cognitive symptoms emerge.